Recent Patents on Anti-Cancer Drug Discovery


Become EABM
Become Reviewer

Editorial [Hot topic: Stresses, Death Receptors and Plasma Membrane (Guest Editors: Patrick Legembre and Faustino Mollinedo)] promotion: free to download

Volume:6   Issue: 3
Pp: 271-273
Patrick Legembre and Faustino Mollinedo
DOI: 10.2174/157489211796957810

Lipid Rafts and Fas/CD95 Signaling in Cancer Chemotherapy

Volume:6   Issue: 3
Pp: 274-283
Consuelo Gajate and Faustino Mollinedo
DOI: 10.2174/157489211796957766

Ceramide in Chemotherapy of Tumors

Volume:6   Issue: 3
Pp: 284-293
Marie-Therese Dimanche-Boitrel, Amelie Rebillard and Erich Gulbins
DOI: 10.2174/157489211796957838

Therapeutic Targeting of CD95 and the TRAIL Death Receptors

Volume:6   Issue: 3
Pp: 294-310
Jeannette Gerspach, Klaus Pfizenmaier and Harald Wajant
DOI: 10.2174/157489211796957739

Regulating TRAIL Receptor-Induced Cell Death at the Membrane: A Deadly Discussion open access plus

Volume:6   Issue: 3
Pp: 311-323
Sarah Shirley, Alexandre Morizot and Olivier Micheau
DOI: 10.2174/157489211796957757

Teaching New Dogs Old Tricks: Membrane Biophysical Properties in Drug Delivery and Resistance

Volume:6   Issue: 3
Pp: 334-346
Nina Milosavljevic, Adam Blanchard, Miriam L. Wahl, Salvador Harguindey, Mallorie Poet, Laurent Counillon and Cyril Rauch
DOI: 10.2174/157489211796957829

Importance of Plasma Membrane Dynamics in Chemical-Induced Carcinogenesis

Volume:6   Issue: 3
Pp: 347-353
Xavier Tekpli, Jorn A. Holme, Odile Sergent and Dominique Lagadic-Gossmann
DOI: 10.2174/157489211796957784

Emerging Targeted Therapies for Pediatric Acute Myeloid Leukemia

Volume:6   Issue: 3
Pp: 354-366
Riccardo Masetti, Katharina Kleinschmidt, Carlotta Biagi and Andrea Pession
DOI: 10.2174/157489211796957775

Emerging Role of Apelin as a Therapeutic Target in Cancer: A Patent Review

Volume:6   Issue: 3
Pp: 367-372
Srujana Rayalam, Mary A. Della-Fera, Thomas Kasser, William Warren and Clifton A. Baile
DOI: 10.2174/157489211796957856

New Therapeutic Strategies for Castration-Resistant Prostate Cancer

Volume:6   Issue: 3
Pp: 373-383
Tomoaki Tanaka and Tatsuya Nakatani
DOI: 10.2174/157489211796957793

Drug Combinations Enhancing the Antineoplastic Effects of Erlotinib in High-Grade Glioma

Volume:6   Issue: 3
Pp: 384-394
Georg Karpel-Massler, Christian R. Wirtz and Marc-Eric Halatsch
DOI: 10.2174/157489211796957748

Patent Selections promotion: free to download

Volume:6   Issue: 3
Pp: 395-396
Bentham Science Publishers
DOI: 10.2174/157489211796957847